Trial Profile
Treatment with bevacizumab for ocular vascular lesions
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 23 May 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Eye disorders
- Focus Therapeutic Use
- 23 May 2016 New trial record